je.st
news
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): The ...
2013-08-18 08:42:48| Biotech - Topix.net
On the surface, GlaxoSmithKline plc 's release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc 's competing Duchenne Muscular Dystrophy drug, eteplirsen.
Tags: the
plc
adr
therapeutics
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||